View by type:
Other(716)
In 2021, we launched a new strategy with ambitious goals and targets.
Expanding sustainable vaccine manufacturing in Africa: Priorities for Support
Delivered by Gavi and partners in response to a call from the African Union and G7 Development Ministers
COVAX: key learnings for future pandemic preparedness and response
The COVID-19 pandemic has demonstrated the clear need for the world to be better prepared the next time a public health emergency of this scale strikes. Rapid and equitable global access to medical interventions, such as therapeutics, diagnostics…
COVAX in humanitarian settings
Addressing the most unpredictable and hard-to-fill gaps in access.
A New Era of Vaccine Manufacturing in Africa
One of the prominent issues exposed by the COVID-19 pandemic is the urgent need to further diversify global vaccine manufacturing, particularly with regards to Africa. With the political realities of nationalism, trade barriers, and the absence…
Taking Stock of Humanitarian Access to Pandemic Vaccines
COVAX was launched in 2020 with equity as its foundational principle, and fundamental to its design from the outset was a vision to address the most unpredictable and hardest to fill gaps in global COVID-19 vaccine access.
The Learning System is an approach that enables use of data and evidence to strengthen delivery of Gavi’s strategies, policies, and programmes.
Welcome to Gavi’s 2021 Annual Progress Report, the first of the 2021–2025 strategic period.
Gavi’s approach to engaging with middle-income countries
A key tool for addressing threats to equity and sustainability.
Evaluation of the drivers of urban immunisation in Uganda: a case study of Kampala city
Gavi, the Vaccine Alliance appointed the Infectious Diseases Research Collaboration (IDRC), Uganda, to conduct an evaluation of the drivers of urban immunization in Uganda with Kampala City as case study.